The synthesis of a series of CgPAr ligands is reported, where CgP is the 6-phospha-2,4,8-trioxa-1,3,5,7-tetramethyladamant-6-yl moiety and Ar = 2-pyridyl (L2), 3-pyridyl (L3), 2-pyrimidyl (L4), 4-R-2-pyridyl [R = Me (L5a), CF (L6a), SiMe (L7a)] or 6-R-2-pyridyl [R = Me (L5b), CF (L6b), SiMe (L7b). Testing of these ligands in the Pd-catalysed methoxycarbonylation of phenylacetylene reveals that the activity and branched selectivity of the catalysts derived from these ligands varies as a function of the N-heterocycle, with the catalyst derived from L5b being the most active of those tested. This, together with the poor performance of catalysts derived from L3 supports the hypothesis that the catalysis proceeds by a "proton shuttling" mechanism, an idea that previously had only been applied to arylphosphines. Reaction of [PtCl(cod)] with L where L = L2 or L4-7 yields a rac/meso mixture of the trans-[PtCl(L)] (1a-h) complexes, three of which are structurally characterised. P NMR spectroscopy shows that reaction of L3 with [PtCl(cod)] gives a mixture of mononuclear and binuclear metal complexes in solution. The complex trans-[PdCl(L2)] (4) reacts with AgBF to give the [PdCl(κ-L2)(κ-L2)]BF (5) with spectroscopic and structural characterisation confirming the presence of a P,N-chelate. H andP NMR evidence supports the assignment of a pyridyl-protonated species being formed upon treatment of 4 with TsOH·HO in CDCl; both the protonated species and chelate 5 are observed when the reaction is carried out in MeOH.
From the evidence of the Mo(0), Pt(0) and Rh(i) complexes of cyclic fluorophosphites containing 5- to 8-membered rings, the binding properties depend critically on the ring size.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.